197 related articles for article (PubMed ID: 29561294)
1. High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis.
Valencia J; Ryan P; Alvaro-Meca A; Troya J; Gutierrez J; Cuevas G; Moreno S
AIDS; 2018 Jun; 32(9):1157-1163. PubMed ID: 29561294
[TBL] [Abstract][Full Text] [Related]
2. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
Valencia La Rosa J; Ryan P; Alvaro-Meca A; Troya J; Cuevas G; Gutiérrez J; Moreno S
PLoS One; 2018; 13(10):e0204795. PubMed ID: 30281616
[TBL] [Abstract][Full Text] [Related]
3. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
5. Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program.
Giuliani M; Caprilli F; Gentili G; Maini A; Lepri AC; Prignano G; Palamara G; Giglio A; Crescimbeni E; Rezza G
Sex Transm Dis; 1997 Oct; 24(9):533-7. PubMed ID: 9339972
[TBL] [Abstract][Full Text] [Related]
6. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
[TBL] [Abstract][Full Text] [Related]
7. [Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France].
Bruandet A; Lucidarme D; Decoster A; Ilef D; Harbonnier J; Jacob C; Delamare C; Cyran C; Van Hoenacker AF; Frémaux D; Josse P; Emmanuelli J; Le Strat Y; Filoche B; Desenclos JC
Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S15-1S22. PubMed ID: 17073126
[TBL] [Abstract][Full Text] [Related]
8. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
9. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
12. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence.
Rezza G; Sagliocca L; Zaccarelli M; Nespoli M; Siconolfi M; Baldassarre C
Scand J Infect Dis; 1996; 28(1):27-9. PubMed ID: 9122628
[TBL] [Abstract][Full Text] [Related]
13. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
van Beek I; Dwyer R; Dore GJ; Luo K; Kaldor JM
BMJ; 1998 Aug; 317(7156):433-7. PubMed ID: 9703523
[TBL] [Abstract][Full Text] [Related]
14. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China.
Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM
Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.
Hagan H; Thiede H; Des Jarlais DC
Epidemiology; 2004 Sep; 15(5):543-9. PubMed ID: 15308953
[TBL] [Abstract][Full Text] [Related]
16. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
17. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
[TBL] [Abstract][Full Text] [Related]
18. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.
Haydon GH; Flegg PJ; Blair CS; Brettle RP; Burns SM; Hayes PC
Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):485-9. PubMed ID: 9855064
[TBL] [Abstract][Full Text] [Related]
19. Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.
Leon L; Kasereka S; Barin F; Larsen C; Weill-Barillet L; Pascal X; Chevaliez S; Pillonel J; Jauffret-Roustide M; LE Strat Y
Epidemiol Infect; 2017 Apr; 145(5):895-907. PubMed ID: 28004616
[TBL] [Abstract][Full Text] [Related]
20. Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.
Zou X; Ling L; Zhang L
BMJ Open; 2015 Aug; 5(8):e008162. PubMed ID: 26297365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
